Suggestions
Jeff Bird
Managing Director at Bluebird Ventures
Jeff Bird is a prominent figure in the life sciences investment sector and currently serves as a Board Member at Stanford Health Care since February 2022. He is also the Managing Director of Bluebird Ventures, which he founded in 2019 after nearly two decades at Sutter Hill Ventures, where he focused on early-stage life sciences companies.145
Education and Early Career
Jeff Bird holds a Bachelor's degree, MD, and PhD in Cancer Biology from Stanford University. His extensive experience includes significant roles in major biotech firms. Notably, he was the CEO of Verinata Health, a company specializing in non-invasive prenatal diagnostics that was acquired by Illumina in 2013. After the acquisition, he served as General Manager at Illumina for a brief period to assist with commercialization efforts.123
Investment and Board Memberships
Bird has been instrumental in several successful biotech ventures. He has served on the boards of various companies, including:
- Portola Pharmaceuticals (acquired by Alexion)
- Forty Seven, Inc. (acquired by Gilead)
- Helix
- Epirium Bio
- Procyrion
His investment strategy has led to significant contributions in immuno-oncology and genomic sequencing sectors.1245
Contributions to Healthcare
At Stanford Health Care, Bird's role on the board involves guiding strategic decisions that impact healthcare delivery and innovation. His background as a physician and investor provides him with a unique perspective on integrating medical advancements with business strategies.45
Personal Interests
Outside of his professional commitments, Jeff Bird enjoys music and is known to be an active musician, playing guitar and singing in a local band.2
Overall, Jeff Bird's combination of medical expertise and investment acumen positions him as a key player in advancing healthcare through innovative technologies and strategic partnerships.
